Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001
NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology
Goldgroup Announces US$75 Million Private Placement with US$60 Million Already Committed by Leading Natural Resource Investors
CUAI - Copper Intelligence Extensive Drilling Program Continues to Validate Significant Copper System at Butembo, Eastern DRC
Syntholene Completes Phase One of Effects Testing at Iceland Demonstration Facility, Advances to High-Power Operations
